LAKE FOREST, Ill., Aug. 25 /PRNewswire/ — David N. Jonas,
Chairman and CEO of PharMEDium Healthcare Corporation announced the
election of William R. Spalding to the company’s Board of
Directors.
Spalding is Co-founder and Principal of The Crawford Spalding
Group, an advisory and management services firm that applies
extensive operational, financial and transactional expertise to
assist companies primarily in the healthcare services industry.
Jonas stated, “Bill’s experience in the healthcare services
industry and his expertise with respect to matters of strategy,
corporate development, operations and governmental affairs equip
him well to add value to PharMEDium as a member of our Board of
Directors going forward. He will be an asset.”
Mr. Spalding’s career experience includes EVP Strategy and
Managed Care for CVSCaremark Inc., a Fortune 20 company, and Senior
Partner in the Atlanta office of King & Spalding LLP, where he
led the Private Equity & Investment Funds Practice and was a
member of the firm’s management committee.
PharMEDium is the national leading provider of pharmacy sterile
intravenous admixture compounding services. The PharMEDium network
of state licensed and federally registered compounding centers
provides trusted solutions to hospitals throughout the United
States. PharMEDium complies with all applicable state laws and FDA
regulations, including USP Chapter <797>, and DEA
requirements. For more information on PharMEDium, visit www.pharmedium.com.
‘/>”/>
